MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
IMRN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Immuron (IMRN) Ownership - Who owns Immuron?

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
25-37, Chapman Street
Phone
+61 388924854
Employees
8
Web
https://www.immuron.com.au

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
7.83M
P/E Ratio
N/A
Total Cash
10M
Projected Growth
N/A
Total Debt
N/A
Revenue
7.48M
Risk (Beta)
1.64
Dividend Yield
N/A
Total Cash/Share
1.22
Total Debt/Equity
N/A
Revenue/Share
0.82 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
IMRN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for IMRN
A.I. Advisor
published General Information

General Information

a biopharmaceutical company

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
25-37, Chapman Street
Phone
+61 388924854
Employees
8
Web
https://www.immuron.com.au